LEADER 01114nam  2200385   450 
001 9910586643303321
005 20221013182056.0
010   $a1-83881-943-6
035   $a(CKB)4950000000722096
035   $a(NjHacI)994950000000722096
035   $a(EXLCZ)994950000000722096
100   $a20221013d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aBiosimilars /$fedited by Valderilio Feijo? Azevedo and Robert Moots
210  1$aLondon, United Kingdom :$cIntechOpen,$d2022.
215   $a1 online resource (106 pages) $cillustrations some color
311   $a1-83881-935-5 
320   $aIncludes bibliographical references.
606   $aBiologicals
606   $aBiopharmaceutics
615  0$aBiologicals.
615  0$aBiopharmaceutics.
676   $a615.7
702   $aMoots$b Robert
702   $aFeijo? Azevedo$b Valderilio
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910586643303321
996   $aBiosimilars$92180041
997   $aUNINA